Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE DM)
Conditions: Diabetes Mellitus; Pre Diabetes; ASCVD Interventions: Drug: high-intensity statin arm; Drug: low-intensity statin plus ezetimibe Sponsors: CardioVascular Research Foundation, Korea; Yuhan Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 14, 2022 Category: Research Source Type: clinical trials